Starlight Cardiovascular

Starlight Cardiovascular focuses on creating medical devices specifically designed to address congenital heart disease in pediatric patients. Recognizing that existing treatments were predominantly developed for adults, the company aims to enhance the effectiveness of care for infants and children. Their portfolio includes regenerative and infection-resistant devices, particularly in the realm of cardiovascular patches, which facilitate improved clinical outcomes for substitute conduit arteries. By targeting the unique anatomical and physiological needs of young patients, Starlight Cardiovascular seeks to reduce morbidity and mortality rates, while also increasing access to essential medical care.